IGF-1 LR3 Vials
|IGF1 LR3 Receptor Grade|
|Molar Mass||9117.60 g·mol−1|
|IUPAC Name||insulin-like growth factor-1 long arginine 3|
IGF-1 LR3 Vials are a research product featuring Insulin-Like Growth Factor 1 Long R3 (IGF-1 LR3), an extended variant of IGF-1 renowned for its heightened bioactivity. These vials are expressly crafted for precise and consistent utilization in research applications, adhering to rigorous quality control measures to ensure reliability.
IGF-1 LR3 Vials are distinguished by the inclusion of the extended variant of Insulin-Like Growth Factor 1 (IGF-1 LR3), renowned for its advanced bioactivity, ensuring heightened efficacy in research applications. Meticulously formulated for precision, these vials provide researchers with a consistent source of IGF-1 LR3, facilitating accurate and reproducible results across experiments. Manufactured under stringent quality control measures, the product upholds reliability and integrity, meeting the high standards necessary for scientific research and experimentation.
IGF-1 LR3 Vials find application in diverse scientific inquiries, specifically in studies focused on cellular growth, metabolism, and muscle-related conditions.
May Potentially Promote Cell Division
Preliminary research indicates that IGF-1 LR3 may have the capacity to promote cell division, making it a compelling subject for investigations into cellular growth and regeneration.
Potentially Boosts Fat Metabolism and Fights Diabetes
Emerging studies propose that IGF-1 LR3 might play a role in enhancing fat metabolism, presenting a potential avenue for research in the realm of diabetes management. This warrants further scrutiny in controlled research settings.
May Potentially Impair Myostatin
Early evidence suggests that IGF-1 LR3 may have the potential to impair myostatin, a key regulator of muscle growth. This opens doors for research into conditions associated with muscle development and wasting.
IGF-1 LR3 Vials stand as a valuable asset for scientific researchers investigating the potential benefits of IGF-1 LR3 in controlled laboratory environments. These vials are intended exclusively for research purposes, and researchers are urged to explore and contribute to the understanding of IGF-1 LR3’s impact on cellular biology, metabolism, and muscle-related conditions.
- Assefa B, Mahmoud AM, Pfeiffer AFH, Birkenfeld AL, Spranger J, Arafat AM. Insulin-Like Growth Factor (IGF) Binding Protein-2, Independently of IGF-1, Induces GLUT-4 Translocation and Glucose Uptake in 3T3-L1 Adipocytes. Oxid Med Cell Longev. 2017;2017:3035184. doi: 10.1155/2017/3035184. Epub 2017 Dec 20. PMID: 29422987; PMCID: PMC5750484. [Read More]
- Carroll PV, Christ ER, Umpleby AM, Gowrie I, Jackson N, Bowes SB, Hovorka R, Croos P, Sönksen PH, Russell-Jones DL. IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp. Diabetes. 2000 May;49(5):789-96. doi: 10.2337/diabetes.49.5.789. PMID: 10905488. [Read More]
- Lang CH, Frost RA, Svanberg E, Vary TC. IGF-I/IGFBP-3 ameliorates alterations in protein synthesis, eIF4E availability, and myostatin in alcohol-fed rats. Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E916-26. doi: 10.1152/ajpendo.00554.2003. Epub 2004 Jan 28. PMID: 14749210. [Read More]